Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-009302
Filing Date
2022-04-06
Accepted
2022-04-06 21:58:00
Documents
1
Period of Report
2021-12-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2866
  Complete submission text file 0001493152-22-009302.txt   4321
Mailing Address C/O SRKP 1, INC. 1900 AVENUE OF THE STARS, SUITE 310 LOS ANGELES CA 90067
Business Address
KRINSKY GLENN (Reporting) CIK: 0001307773 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39717 | Film No.: 22812185

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations